openPR Logo
Press release

Emerging Frontiers in Oncolytic Virus Immunotherapy: Market Trends, Therapeutic Advancements, and Clinical Breakthroughs

10-10-2023 10:07 PM CET | Health & Medicine

Press release from: Persistence Market Research

Oncolytic Virus Immunotherapy Market

Oncolytic Virus Immunotherapy Market

Market Overview:
The Oncolytic Virus Immunotherapy market refers to the rapidly evolving field of cancer treatment that utilizes oncolytic viruses to stimulate the patient's immune system to target and destroy cancer cells. Oncolytic viruses are modified viruses that selectively infect and replicate within tumor cells, leading to their destruction and triggering an immune response against cancer. This innovative approach holds promising potential as a novel and targeted cancer therapy.

Market Size and Growth:
The global Oncolytic Virus Immunotherapy market was valued at USD $154.39 Million in 2022. It is expected to grow at a robust CAGR of 25.14% from 2022 to 2031, reaching a projected value of USD $1,146.40 Million by the end of the forecast period. The market's growth is primarily driven by increasing research and development activities, growing awareness of immunotherapies, and promising results from clinical trials.

Seeking Deeper Insights into Competitor Analysis? Request a Sample of the Report Now! https://www.persistencemarketresearch.com/samples/15262

Market Segmentation:
By Virus Type:
• Adenovirus
• Herpes Simplex Virus
• Measles Virus
• Vesicular Stomatitis Virus
• Others

By Cancer Type:
• Melanoma
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Others

By End-User:
• Hospitals and Clinics
• Research Institutes
• Biopharmaceutical Companies

Regional Analysis:
North America dominates the Oncolytic Virus Immunotherapy market, followed by Europe and the Asia Pacific. The region's leading position can be attributed to the presence of major biopharmaceutical companies, well-established healthcare infrastructure, and favorable regulatory support for immunotherapies. The Asia Pacific region is expected to witness significant growth during the forecast period, driven by increasing investments in healthcare research and development and a rising prevalence of cancer.

For Customized Insights on Segments, Regions, or Competitors, Request Personalized Purchase Options@ https://www.persistencemarketresearch.com/request-customization/15262

Key Players:
The Oncolytic Virus Immunotherapy market is highly competitive, with various biopharmaceutical companies and research institutes involved in the development and commercialization of oncolytic virus-based therapies. Key players in the market include:
• Amgen Inc.
• Oncolytics Biotech Inc.
• Viralytics Limited (Merck & Co., Inc.)
• PsiOxus Therapeutics Ltd.
• Sorrento Therapeutics, Inc.
• Targovax ASA
• Shanghai Sunway Biotech Co., Ltd.
• SillaJen Biotherapeutics, Inc.
• Lokon Pharma AB
• Transgene SA

Market Drivers:
• Rising incidence of cancer globally and the need for effective and targeted therapies.
• Advancements in gene therapy and viral vector technology.
• Increasing focus on personalized medicine and precision oncology.
• Supportive regulatory environment for immunotherapies.

Challenges:
• Complexities associated with viral engineering and optimization.
• High costs and logistical challenges in manufacturing and distributing oncolytic viruses.
• Potential adverse effects and safety concerns related to virus-based therapies.

Trends:
• Collaboration and partnerships between biopharmaceutical companies and research institutes for clinical development.
• Combination therapies with other immunotherapies and traditional cancer treatments.
• Development of next-generation oncolytic viruses with enhanced tumor targeting and immunomodulatory properties.

Unlock Exclusive Insights into Business Opportunities and Market Value - Get the Premium Insight Now! https://www.persistencemarketresearch.com/checkout/15262

Future Projections:
The Oncolytic Virus Immunotherapy market is poised for significant growth in the coming years. The ongoing research and clinical trials, along with regulatory approvals for new therapies, will drive market expansion. Additionally, the growing adoption of personalized medicine approaches and advancements in understanding the tumor microenvironment will further fuel the development and commercialization of oncolytic virus-based immunotherapies.

Explore the Latest Trend: Dive into the Exclusive "PMR" Article -
• North America Vet Compounding Pharmacies Market Forecast - https://www.persistencemarketresearch.com/market-research/north-america-vet-compounding-pharmacies-market.asp

• Europe Urethral Bulking Systems Market CAGR - https://www.persistencemarketresearch.com/market-research/europe-urethral-bulking-systems-market.asp

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerging Frontiers in Oncolytic Virus Immunotherapy: Market Trends, Therapeutic Advancements, and Clinical Breakthroughs here

News-ID: 3244115 • Views:

More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by Sustainability and Supply Chain Efficiency
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Growth - Persistence Market Research
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Healthcare Demand
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained

All 5 Releases


More Releases for Virus

Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects. Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817 The outbreak of Zika virus infection in Latin
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism